Product Images Methylphenidate Hydrochloride

This text provides information about a medication containing 18 mg of methylphenidate hydrochloride in tablet form. It includes storage instructions, dosage information, and details for dispensing. The medication is an extended-release formula and the product is distributed by GSMS, Incorporated. It is essential to keep this medication in tight containers, away from children, and protected from moisture and humidity. Pharmacists should provide the Medication Guide separately to each patient when dispensing.*

The text provides information about methylphenidate hydrochloride tablets containing 27 mg. It includes dosing instructions, storage guidelines, and contact details for the marketer. The medication is an extended-release formulation and should be kept in tight containers to protect from moisture. Pharmacists are advised to dispense a Medication Guide to each patient.*

This text provides details about a medication containing 36 mg of methylphenidate hydrochloride in tablet form. The dosage information is advised to be checked in the accompanying prescribing information. It should be stored at a temperature range of 20° - 25°C to protect from moisture and humidity. The medication is dispensed in tight containers to keep it secure, and it is important to keep it out of reach of children. The product is marketed by GSMS, Incorporated in Camarillo, USA. It is an extended-release tablet and the packaging includes 100 tablets. Pharmacies are instructed to dispense a Medication Guide separately to each patient.*

This text provides information about methylphenidate hydrochloride extended-release tablets. Each tablet contains 54 mg of the active ingredient. It also includes storage instructions, dosage details, and a reminder to keep the medication out of reach of children. The text also mentions the pharmaceutical company, GSMS Inc., based in Camarillo, CA. Pharmacists are instructed to dispense a Medication Guide to each patient. The product is available in bottles containing 100 tablets.*

This information shows the mean plasma concentrations of Methylphenidate in ng/mL for two different dosing regimens: 18mg once daily extended-release tablets and 5mg three times daily. The data reveals concentration levels at specific time points ranging from 16 to 32 ng/mL.*

This text appears to be a list of elements related to a study or clinical trial involving a medication called Methylphenidate Hydrochloride. The study involved three different phases or studies labeled as "Study1," "Study2," and "Study3," possibly evaluating the effects or efficacy of the medication. The medication was administered in the form of extended-release tablets once daily. The text also mentions "Symptoms" associated with the medication and "Placebo." It seems to indicate some numerical or graphical data with values such as "90 @1," "Week 4," and various symbols and numbers.*